FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

4360711000001109: Avelox 400mg tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17941701000001113 Avelox 400mg tablets (Bayer Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17941801000001116 Avelox 400mg tablets (Bayer Plc) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Avelox 400mg tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Is a Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has active ingredient Moxifloxacin hydrochloride false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Is a Avelox true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Moxifloxacin true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has specific active ingredient Moxifloxacin hydrochloride true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) Has basis of strength substance Moxifloxacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Avelox 400mg tablets (Bayer Plc) 5 tablet Is pack of False Avelox 400mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has AMP True Avelox 400mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start